Clinical Trial Update: Comparison of Telbivudine Plus Adefovir With Lamivudine Plus Adefovir for the Treatment of Lamivudine-resistant Chronic Hepatitis B at 52 Weeks: A Pilot Study [Phase 4]

View source ↗

Summary

A Phase 4 pilot trial compares telbivudine plus adefovir versus lamivudine plus adefovir for lamivudine-resistant chronic hepatitis B, with evaluation through 5…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Adefovir Dipivoxil (Adefovir dipivoxil)
• Lamivudine (lamivudine)
• Telbivudine (telbivudine)

Snippet

Sponsor: Korea University | Conditions: Chronic Hepatitis B | Phase 4 | Status: UNKNOWN